Affiliation:
1. Department of Microbiology, Hospital Clínic, School of Medicine, University of Barcelona, Barcelona
2. Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0560
3. School of Health Science, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, 35016, Spain
Abstract
ABSTRACT
Elevated levels of fluoroquinolone resistance are frequently found among
Escherichia coli
clinical isolates. This study investigated the antibiotic resistance mechanisms of strain NorE5, derived
in vitro
by exposing an
E. coli
clinical isolate, PS5, to two selection steps with increasing concentrations of norfloxacin. In addition to the amino acid substitution in GyrA (S83L) present in PS5, NorE5 has an amino acid change in ParC (S80R). Furthermore, we now find by Western blotting that NorE5 has a multidrug resistance phenotype resulting from the overexpression of the antibiotic resistance efflux pump AcrAB-TolC. Microarray and gene fusion analyses revealed significantly increased expression in NorE5 of
soxS
, a transcriptional activator of
acrAB
and
tolC
. The high
soxS
activity is attributable to a frameshift mutation that truncates SoxR, rendering it a constitutive transcriptional activator of
soxS
. Furthermore, microarray and reverse transcription-PCR analyses showed that
mdtG
(
yceE
), encoding a putative efflux pump, is overexpressed in the resistant strain. SoxS, MarA, and Rob activated an
mdtG
::
lacZ
fusion, and SoxS was shown to bind to the
mdtG
promoter, showing that
mdtG
is a member of the
marA-soxS-rob
regulon. The
mdtG
marbox sequence is in the backward or class I orientation within the promoter, and its disruption resulted in a loss of inducibility by MarA, SoxS, and Rob. Thus, chromosomal mutations in
parC
and
soxR
are responsible for the increased antibiotic resistance of NorE5.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference49 articles.
1. Alos, J. I. 2005. Epidemiology and etiology of urinary tract infections in the community. Antimicrobial susceptibility of the main pathogens and clinical significance of resistance. Enferm. Infecc. Microbiol. Clin.23(Suppl. 4):3-8. (In Spanish.)
2. Amabile-Cuevas, C. F., and B. Demple. 1991. Molecular characterization of the soxRS genes of Escherichia coli: two genes control a superoxide stress regulon. Nucleic Acids Res.19:4479-4484.
3. Arslan, H., O. K. Azap, O. Ergonul, and F. Timurkaynak. 2005. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J. Antimicrob. Chemother.56:914-918.
4. Defining a
rob
Regulon in
Escherichia coli
by Using Transposon Mutagenesis
5. Chenia, H. Y., B. Pillay, and D. Pillay. 2006. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens. J. Antimicrob. Chemother.58:1274-1278.
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献